Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson crawled time : 12:00 save search
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
RXRX | $7.66 -1.67% 1.3M
|
Professional, Scientific, and T...
|
| O: -10.0%
H: 0.0%
C: 0.0%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
commercial
Johnson & Johnson Reports Q1 2024 Results
Published: 2024-04-16 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
results
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
Published: 2024-04-16 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
year
AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Published: 2024-04-15 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
avb-101 first dementia for trial
Johnson & Johnson to Acquire Shockwave Medical
Published: 2024-04-05 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
SWAV | $327.9 0.06% 550K
|
Health Technology
|
| O: 1.21%
H: 0.65%
C: 0.25%
acquire medical
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
TRIB | $1.86 12K
|
Health Technology
|
| O: -0.99%
H: 2.0%
C: 2.0%
biotech business year financial results
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
CMPS | $8.23 -1.08% 110K
|
Health Technology
|
| O: -1.79%
H: 0.21%
C: -10.83%
The9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic
Published: 2024-03-26 (Crawled : 12:00) - prnewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
NCTY | $5.625 31K
|
Technology Services
|
| O: 6.25%
H: 0.0%
C: -4.2%
precision disease agreement platform
Christi Shaw, Former CEO of Kite, a Gilead Company, Appointed to Cellares Advisory Board to Advance Cell Therapy Manufacturing
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ceo cell therapy
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
PTGX | $26.06 -1.96% 95K
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.48%
update therapeutics
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
Published: 2024-03-25 (Crawled : 12:00) - prnewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
fda approval treatment application platform
J&J Wins FDA Nod for Pulmonary Arterial Hypertension Combo Pill
Published: 2024-03-25 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
fda hypertension
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001
Published: 2024-03-22 (Crawled : 12:00) - prnewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
lnk0100 first dermatitis pharmaceuticals study
RYBREVANT® (amivantamab-vmjw) data at ELCC advance Johnson & Johnson's ambition to transform the standard of care for patients with EGFR-mutated non-small cell lung cancer
Published: 2024-03-18 (Crawled : 12:00) - prnewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
rybrevant lung cancer cell care
Major shareholder announcement – Invesco Ltd.
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
announcement
Major shareholder announcement – AIM International Mutual Funds
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
announcement international
Major shareholder announcement – BlackRock, Inc.
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
BLK | $757.54 -0.71% 150K
|
Finance
|
| O: 0.46%
H: 0.01%
C: -0.74%
announcement
FOOT LOCKER, INC. NAMES CINDY CARLISLE CHIEF HUMAN RESOURCES OFFICER
Published: 2024-03-13 (Crawled : 12:00) - prnewswire.com
SYK | $338.95 -0.05% 590K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: -0.76%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
FL | $21.425 -2.61% 620K
|
Retail Trade
|
| O: -1.11%
H: 0.5%
C: -3.7%
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 12:00) - globenewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
MRSN | $3.8 0.26% 120K
|
Health Technology
|
| O: -5.39%
H: 24.13%
C: 20.05%
business year update therapeutics financial results
We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for ...
Published: 2024-02-22 (Crawled : 12:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.59%
H: 1.11%
C: 0.92%
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 2.37%
H: 1.51%
C: 0.79%
Gainers vs Losers
| 50% | 50% |
Top 10 Gainers
TPET | $0.4951 114.24% 29M
|
n/a
WISA 4 | $3.22 84.0% 56M
|
Electronic Technology
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.